Disseminated Intravascular Coagulation, commonly known as DIC, is not a primary disease itself. Instead, it is a severe secondary complication where the body's normal blood clotting system becomes wildly overactive. In obstetric practice, midwives must understand that pregnancy creates a naturally hypercoagulable state to protect women from postpartum hemorrhage. When certain pregnancy complications strike, this protective mechanism spins dangerously out of control, causing widespread clotting followed by catastrophic bleeding.
Major obstetric triggers include:
The development of DIC follows a distinct two-phase pathological sequence that tricks the body's natural healing systems. First is the clotting phase, triggered by massive amounts of tissue factor entering the bloodstream. Tiny blood clots form everywhere inside the microvasculature, cutting off oxygen and nutrients to vital organs like the kidneys and brain. This widespread microvascular thrombosis consumes all available platelets and clotting factors.
Once the body's reserves of platelets and fibrinogen are entirely depleted, the condition enters its second phase: the bleeding phase (or consumption coagulopathy). At the same time, the body tries to dissolve the initial widespread clots by activating the fibrinolytic system. Because there are no clotting factors left to seal blood vessel walls, the patient experiences severe, uncontrolled hemorrhage from every possible site, including venipuncture wounds, surgical incisions, and mucous membranes.
Midwives must maintain high clinical suspicion because DIC presents with a confusing mix of both clotting and bleeding signs. Clinical features depend entirely on whether microvascular thrombosis or severe hemorrhage is currently dominating the patient's presentation.
Diagnosis relies on both clinical observations and rapid laboratory confirmation. Midwives must understand that waiting for lab results before starting emergency care is dangerous; however, baseline blood panels are vital to confirm the diagnosis and guide ongoing blood product replacement.
| Laboratory Test | Normal Pregnancy Value | Finding in DIC | Clinical Significance |
|---|---|---|---|
| Platelet Count | 150,000 - 400,000/µL | Decreased (< 100,000/µL) | Indicates consumption of platelets |
| Prothrombin Time (PT) | 11 - 13 seconds | Prolonged | Reflects depletion of clotting factors |
| Fibrinogen Level | 200 - 400 mg/dL | Markedly decreased (< 150 mg/dL) | Strongest predictor of severe bleeding |
| D-Dimer | Low / Negative | Elevated | Proves widespread clot breakdown |
The absolute golden rule in managing obstetric DIC is to treat the underlying trigger immediately. No amount of blood transfusion will stop the bleeding if a retained dead fetus, retained placenta, or active placental abruption remains inside the uterus.
Simultaneously, aggressive resuscitation must begin:
Medical management focuses on replacing what has been lost using specific blood components guided by laboratory results and clinical bleeding. Midwives work closely with medical officers and hematologists to ensure accurate replacement therapy.
Heparin is rarely used in established obstetric DIC because the patient is already bleeding profusely, though it may occasionally be considered in very early or chronic cases under specialist supervision.
Continuous, vigilant monitoring is the cornerstone of safe nursing care for a woman with DIC. The midwife acts as the patient's primary line of defense by detecting subtle clinical changes before they escalate into cardiac arrest.
Maintain strict fluid balance charts. Every milliliter of urine output must be measured; an output dropping below 30 mL/hour signals failing kidney perfusion. Inspect all surgical wounds, episiotomies, and intravenous insertion sites every 15 to 30 minutes for fresh bleeding or hematoma formation. Provide constant psychological reassurance to both the mother and her family, as the sudden emergency and intensive care environment cause immense fear. Finally, ensure all blood component transfusions are checked meticulously against patient identification bands to prevent fatal transfusion reactions during an already fragile medical crisis.